Sustaining proliferative signals (oncogenes) Lecture 7 Flashcards

1
Q

Define proto-oncogene and oncogene

A

Proto-oncogene - promotes normal cell growth and proliferation in a regulated manner

Oncogene = mutated forms of the correpotentially cancer causing gene, novel/unregulated functions, High level of expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How can oncogenes be amplified to cause cancer?

A

Gain function mutations - only one allele needs to be mutated

Point mutation -> encoded protein with altered characteristics

Amplification of genomic DNA segment including proto-oncogene which leads to overexpression

Chromosomal Translocation that brings a growth regulatory gene under control of a different promoter giving inappropriate gene and protein expression

Chromosomal Translocation that joins two genes together -> creates a chimeric fusion gene and protein with novel characteristics e.g. BCR and ABL

Chromosomal translocation eg. 8:14/2/22 in Burkitts lymphoma The c-myc gene is placed near the immunoglobulin genes which are highly expressed in B cells and the expression of the c-myc gene is then constitutively increased Gene replication Double minute chromosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key concept of oncogens

A

2 normal alleles produces normal protein

1 normal and 1 mutated allele produces half normal and half mutant protein

DNA amplification produces too much of normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Ras

A

Molecular switch

Can be present in active (GTP bound) or inactive (GDP bound) form

In mutated RAS it gets blocked in active form by blocking of intrinsic GTPase activity

Commonest oncogene mutated in human tumours

Common cancer causeing mutations at codons 12,13 or 61

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is MYC?

A

MYC is a Transcription Factor

  • Usually binds E-box element located within promoters of target genes to upregulate them
  • Works with MAX to recruit additional co-activators to the promoter of the target gene
  • MAX also works with MAD1 to repress gene expression
  • MYC proteins compete with MAD1 for binding to MAX

A MYCN amplification - takes two forms in causing neuroblastoma:

  • Double minutes - chromatin structures without centromeres/telomeres
  • Homogeneously staining region - hundreds of copies of MYC inserted into another chromosome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Within chromosome translocation that brings a grwoth regulatory gene under the control of a different promotor, descirbe the action of MTC and IGH giving inappropraite gene expression

A
  • MYC gene is divided into its promoter regions
  • In the translocation you get breakpoints where the coding region is separated from the regulatory segment
  • On IGH there is a constant region and enhancer sequences
  • Consequence of translocation is that coding region of MYC is brought under enhancer sequence of IGH gene - meaning MYC expression is driven instead of Ig gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Within chromosome translocation that joins 2 genes together, What are PML and RARalpha and how can they cause cancer?

A

RARalpha is a nuclear receptor which functions as a Transcription Factor (upon ligand binding) for myeloid differentiation genes. Without ligand binding it represses genes

PML has an important role in cell survival / cycle regulation

When they fuse they homodimerise - enhancing transcriptional repression and silencing of genes important for myeloid differentiation. Also causes self renewal of APL (the most rapidly fatal leukaemia) cells

This causes Acute Myelocytic Leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can APL be treated

A

Retinoic acid - converts PML/RARalpha from a transcriptional repressor to activator. This causes reactivation of genes so myeloid diffrentation is increased

Arsenic trioxide - PML/RARalpha degradation - brings back normal structured nucelar bodies which regulate p53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the importance of tyrosine kinase in cancer?

A

Amino acid changes or over expression can lead to contituative activation or constant phosphorylation and cell growth cascades Eg. Pp60c-src a non-receptor tyrosine kinase- often over expressed in colon, liver, lung, breast and pancreas tumours binds to phosphorylkated receptors and the kinase domain becomes active leading to survival and proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are tyrosine kinase inhibitors work and devlpoed in gernarations

A

How they work

  • EGFR (epidermal growth factor receptor) has extracellular domain where EGF binds
  • Intracellular domain, where kinase is, where ATP binds
  • TKI mimics ATP and can bind to the ATP binding site causing the kinase to not be able to function

Development

First:

  • Competitive ATP-mimics e.g gefitinib
  • Reversible binding
  • Frequent drug resistance

Second:

  • Irreversible binding e.g. afatinib
  • Toxicity is a problem

Third:

  • Bind more avidly to EGFR mutants than wild-type EGFR
  • Less toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly